M06.219
Rheumatoid bursitis, unspecified shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Rheumatoid bursitis of the shoulder is a condition characterized by inflammation of the bursae—the small, fluid-filled sacs that cushion the shoulder joint—caused by rheumatoid arthritis. This chronic autoimmune disorder leads to joint inflammation and can affect various joints throughout the body. When it targets the shoulder, it can cause pain, swelling, and limited movement, impacting daily activities and quality of life. The code M06.219 specifies a diagnosis of rheumatoid bursitis of an unspecified shoulder, indicating the specific shoulder affected has not been identified or documented.
Causes & Symptoms
Clinical Causes: Rheumatoid arthritis: An autoimmune disorder where the immune system mistakenly attacks joint tissues, leading to inflammation of bursae. Recurrent shoulder injuries or overuse: Recurrent trauma or repetitive movements can exacerbate inflammation in the bursae. Infection: Though less common, infections in the bursae can contribute to inflammation alongside rheumatoid disease symptoms. Other autoimmune conditions: Conditions similar to rheumatoid arthritis that involve joint inflammation may also play a role.
Key Symptoms: Persistent shoulder pain, often worsening with movement or activity Swelling and tenderness around the shoulder joint Limited range of motion, making shoulder movements difficult Warmth and redness over the affected area Stiffness, especially after periods of inactivity or rest Weakness in shoulder muscles due to discomfort and decreased use
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and diagnostic tests. Healthcare providers typically perform a physical examination to assess swelling, tenderness, and range of motion. Imaging studies such as ultrasound or MRI can help visualize inflamed bursae and rule out other shoulder conditions. Blood tests may be conducted to identify markers of rheumatoid arthritis, including rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibodies. Sometimes, a sample of the bursae fluid may be extracted via aspiration for analysis to detect infection or crystals but is less common in rheumatoid bursitis cases.
Treatment Protocols: Management of rheumatoid bursitis of the shoulder aims to reduce inflammation, alleviate pain, and restore function. Therapeutic options include: - Nonsteroidal anti-inflammatory drugs (NSAIDs): To decrease inflammation and relieve pain. - Corticosteroid injections: Delivering anti-inflammatory medication directly into the affected bursae for rapid relief. - Disease-modifying antirheumatic drugs (DMARDs): To control the overall activity of rheumatoid arthritis and prevent further joint damage. - Physical therapy: To strengthen shoulder muscles, improve flexibility, and prevent stiffness. - Rest and activity modification: To prevent aggravation of symptoms. - Surgical intervention: In severe or persistent cases, procedures such as bursectomy (removal of the inflamed bursa) may be considered. It is important to follow a comprehensive treatment plan tailored to individual needs, often involving rheumatology specialists and physical therapists.
Clinical Advice & FAQs
Billing Guidance
Is M06.219 a billable ICD-10 code?
Yes, M06.219 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M06.219?
Clinical documentation must specify the nature of Rheumatoid bursitis, unspecified shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference